STAAR Surgical
STAA
181 hedge funds and large institutions have $1.28B invested in STAAR Surgical in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 74 increasing their positions, 62 reducing their positions, and 37 closing their positions.
679% more call options, than puts
Call options by funds: $8.64M | Put options by funds: $1.11M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
19% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 62
4.09% more ownership
Funds ownership: 86.56% → 90.64% (+4.1%)
7% less funds holding
Funds holding: 194 → 181 (-13)
30% less capital invested
Capital invested by funds: $1.83B → $1.28B (-$548M)
32% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 37
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.9M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$24.4M |
| 3 |
BM
Bridger Management
New York
|
+$20M |
| 4 |
Renaissance Technologies
New York
|
+$14.4M |
| 5 |
TA
Teachers Advisors
New York
|
+$8.54M |
Top Sellers
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$15.7M |
| 2 |
Millennium Management
New York
|
-$15.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$10.2M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$9.44M |
| 5 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
-$9.17M |
STAA Hedge Fund Activity: Q4 2018 in Review
181 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q4 2018, worth a combined $1.28B — down 30% from $1.83B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of STAA and 25 opened new positions — a net loss of 12 holders — while 62 trimmed existing stakes and 74 added.
The largest buyer was Vanguard Group, adding an estimated $32.9M. The largest seller was Putnam Investments, cutting an estimated $15.7M.
- 181 institutional investors held STAAR Surgical (STAA) as of Q4 2018, down from 194 in Q3 2018.
- Funds reported $1.28B of STAAR Surgical stock for Q4 2018, down 30% quarter-over-quarter.
- 25 funds opened new STAAR Surgical positions in Q4 2018 and 37 closed out, a net change of -12 holders.
- The largest STAAR Surgical buyer in Q4 2018 was Vanguard Group, an estimated $32.9M added.
- The largest STAAR Surgical seller in Q4 2018 was Putnam Investments, an estimated $15.7M sold.
Based on aggregated 13F filings for Q4 2018.